Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy
Davide Firinu, Giuseppe Fenu, Giuseppina Sanna, et al.
Journal of Autoimmunity (2022) Vol. 131, pp. 102848-102848
Open Access | Times Cited: 10

Showing 10 citing articles:

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Rona Smith, Rachel Jones, Ulrich Specks, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 7, pp. 937-944
Open Access | Times Cited: 61
Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
Natalia Egri, Hugo Calderón, Robert Martinez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency
Cliodhna E. Murray, C. O’Brien, S. Alamin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy
Ashley J. Priddey, Michael Chen‐Xu, Daniel J Cooper, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
COVID-19 monitoring of school personnel through molecular salivary test and dried blood spot analysis
Dolaji Henin, Clara Fappani, Daniela Carmagnola, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 1
The Impact of The COVID-19 Pandemic On SLE
Xingwang Zhao, Haohao Wu, Shifei Li, et al.
Modern Rheumatology (2023)
Open Access | Times Cited: 4
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies
Laura Gragnani, Marcella Visentini, Serena Lorini, et al.
Journal of Translational Autoimmunity (2022) Vol. 5, pp. 100164-100164
Open Access | Times Cited: 5
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003094-e003094
Open Access | Times Cited: 2
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects
Valentina Laquintana, Carla Mottini, Francesco Marchesi, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access
Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD-20 therapy
Ashley J. Priddey, Michael Chen‐Xu, Daniel J Cooper, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top